1. Home
  2. ELVN vs DHC Comparison

ELVN vs DHC Comparison

Compare ELVN & DHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • DHC
  • Stock Information
  • Founded
  • ELVN 2016
  • DHC 1998
  • Country
  • ELVN United States
  • DHC United States
  • Employees
  • ELVN N/A
  • DHC N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • DHC Real Estate Investment Trusts
  • Sector
  • ELVN Health Care
  • DHC Real Estate
  • Exchange
  • ELVN Nasdaq
  • DHC Nasdaq
  • Market Cap
  • ELVN 927.8M
  • DHC 757.5M
  • IPO Year
  • ELVN 2020
  • DHC N/A
  • Fundamental
  • Price
  • ELVN $17.77
  • DHC $3.13
  • Analyst Decision
  • ELVN Strong Buy
  • DHC Hold
  • Analyst Count
  • ELVN 4
  • DHC 3
  • Target Price
  • ELVN $37.25
  • DHC $4.50
  • AVG Volume (30 Days)
  • ELVN 361.5K
  • DHC 919.5K
  • Earning Date
  • ELVN 05-14-2025
  • DHC 05-05-2025
  • Dividend Yield
  • ELVN N/A
  • DHC 1.28%
  • EPS Growth
  • ELVN N/A
  • DHC N/A
  • EPS
  • ELVN N/A
  • DHC N/A
  • Revenue
  • ELVN N/A
  • DHC $1,511,515,000.00
  • Revenue This Year
  • ELVN N/A
  • DHC $5.25
  • Revenue Next Year
  • ELVN N/A
  • DHC $6.48
  • P/E Ratio
  • ELVN N/A
  • DHC N/A
  • Revenue Growth
  • ELVN N/A
  • DHC 5.33
  • 52 Week Low
  • ELVN $13.30
  • DHC $2.00
  • 52 Week High
  • ELVN $30.03
  • DHC $4.24
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 49.54
  • DHC 60.27
  • Support Level
  • ELVN $15.81
  • DHC $2.96
  • Resistance Level
  • ELVN $17.54
  • DHC $3.36
  • Average True Range (ATR)
  • ELVN 1.30
  • DHC 0.15
  • MACD
  • ELVN -0.04
  • DHC -0.00
  • Stochastic Oscillator
  • ELVN 38.06
  • DHC 47.73

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About DHC Diversified Healthcare Trust of Beneficial Interest

Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs. Majority of revenue is from SHOP segment.

Share on Social Networks: